CORT offering history
Every offering-related filing in CORCEPT THERAPEUTICS INC’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,007 filings back to Jun 22, 2015.
| Date | Filing | What it means | |
|---|---|---|---|
| May 10, 2017 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 5, 2017 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Mar 13, 2017 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
CORT offering FAQ
When did CORT last execute an offering?
No executed-offering document (424B pricing supplement or 8-K item 3.02) appears in the 1007 filings EDGAR returns for CORCEPT THERAPEUTICS INC, reviewed back to 2015-06-22.
When did CORT last announce or register an offering?
The most recent registration is a S-3/A filed 2017-05-05. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.